Hereditary angioedema attack: what happens to vasoactive mediators?

Area of Science:

• Immunology
• Vascular Biology
• Biochemistry

Background:

• Hereditary angioedema (HAE) is a severe condition linked to C1 inhibitor deficiency, causing bradykinin buildup and edema.
• Vascular leakage in HAE involves factors like VEGFs, angiopoietins (ANGPTs), and phospholipase A2 (PLA2).
• Previous research showed elevated VEGFs, ANGPTs, and PLA2 in HAE patients during remission.

Purpose of the Study:

• To investigate plasma levels of VEGFs, ANGPTs, and PLA2 during acute hereditary angioedema attacks versus remission.
• To understand the role of these mediators in HAE pathophysiology and attack resolution.

Main Methods:

• Analyzed plasma samples from 15 HAE patients during acute attacks and remission.
• Measured concentrations of VEGF-A, VEGF-C, VEGF-D, ANGPT1, and ANGPT2.
• Assessed platelet-activating factor acetylhydrolase activity.

Main Results:

• VEGF-A, -C, and -D levels did not significantly change between attack and remission phases.
• ANGPT1 levels increased during attacks, while ANGPT2 remained unchanged, decreasing the ANGPT2/ANGPT1 ratio.
• Platelet-activating factor acetylhydrolase activity was elevated in remission but decreased during attacks.

Conclusions:

• Hereditary angioedema attacks are associated with specific alterations in vasoactive mediators, notably ANGPT1.
• The study reveals dynamic changes in vascular mediators during HAE attacks and resolution.
• These findings contribute to understanding HAE pathophysiology and identifying potential therapeutic targets.